Found: 6
Select item for more details and to access through your institution.
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association?
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 14, p. 4102, doi. 10.3390/jcm11144102
- By:
- Publication type:
- Article
Marie Antoinette syndrome following COVID‐19 vaccination.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 7, p. 903, doi. 10.1111/ijd.16262
- By:
- Publication type:
- Article
Tralokinumab efficacy in a case of dupilumab‐resistant severe atopic dermatitis complicated by eczema herpeticum.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 8, p. e1028, doi. 10.1111/jdv.19091
- By:
- Publication type:
- Article
Severe bullous pemphigoid following Covid‐19 vaccination resistant to rituximab and successfully treated with dupilumab.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 2, p. e135, doi. 10.1111/jdv.18673
- By:
- Publication type:
- Article
Rapid and sustained response to tralokinumab in a patient with severe bullous pemphigoid and end-stage kidney disease.
- Published in:
- Clinical & Experimental Dermatology, 2024, v. 49, n. 2, p. 161, doi. 10.1093/ced/llad331
- By:
- Publication type:
- Article